Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,954,865
+$9,406,639 QoQ
Shares Held
602,990
+34.6% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 328 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. HRMY ranks #72 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in HRMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,954,865 | 602,990 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,548,226 | 447,991 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $11,122,271 | 297,228 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $13,864,911 | 503,081 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,074,200 | 160,576 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,058,004 | 182,525 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $8,095,571 | 235,268 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,835,720 | 95,893 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,668,400 | 55,300 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,810,556 | 113,477 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,430,501 | 44,288 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $502,134 | 15,323 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,093,698 | 59,497 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $652,803 | 19,994 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $483,060 | 8,767 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $16,210 | 366 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $66,375 | 1,361 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $526,926 | 10,831 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $985,239 | 23,106 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $695,229 | 18,138 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $780,220 | 27,638 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $235,971 | 7,142 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $466,732 | 12,911 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $745,800 | 22,000 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||